Published in Annu Rev Pharmacol Toxicol on January 01, 1988
Peptide kappa opioid receptor ligands: potential for drug development. AAPS J (2009) 1.39
Stress-induced activation of the dynorphin/κ-opioid receptor system in the amygdala potentiates nicotine conditioned place preference. J Neurosci (2012) 1.18
Changes in prodynorphin gene expression and neuronal morphology in the hypothalamus of postmenopausal women. J Neuroendocrinol (2008) 1.11
Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice. Br J Pharmacol (2001) 0.82
Naloxone prevents cell-mediated immune alterations in adult mice following repeated mild stress in the neonatal period. Br J Pharmacol (2002) 0.81
Response of substances co-expressed in hypothalamic magnocellular neurons to osmotic challenges in normal and Brattleboro rats. Cell Mol Neurobiol (2008) 0.77
Bullatine A stimulates spinal microglial dynorphin A expression to produce anti-hypersensitivity in a variety of rat pain models. J Neuroinflammation (2016) 0.77
Ester Hydrolysis Differentially Reduces Aconitine-Induced Anti-hypersensitivity and Acute Neurotoxicity: Involvement of Spinal Microglial Dynorphin Expression and Implications for Aconitum Processing. Front Pharmacol (2016) 0.76
Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides. J Psychiatry Neurosci (1992) 0.76
Separation of dynorphin peptides by capillary electrochromatography using a polydiallyldimethylammonium chloride gold nanoparticle-modified capillary. Electrophoresis (2016) 0.75
Effect of dynorphin A(1-13) on cardiomyocytes in culture: modulation of the response to increased extracellular calcium, but no effect on intrinsic cardiac contractile frequency or the response to isoproterenol or increased extracellular potassium. Basic Res Cardiol (1992) 0.75
Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact. EMBO J (1989) 1.09
Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. J Pharmacol Exp Ther (1998) 1.08
Ethanol-induced fluidization of brain lipid bilayers: required presence of cholesterol in membranes for the expression of tolerance. Mol Pharmacol (1979) 1.00
Opiate and peptide interaction: effect of enkephalins on morphine analgesia. Eur J Pharmacol (1980) 0.98
A protein-lipid model of the opiate receptor. Life Sci (1980) 0.98
Opioids mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells. J Neurosci (1994) 0.97
Dynorphin interaction at the kappa-opiate site. Eur J Pharmacol (1981) 0.93
Cloning, sequencing and localization to chromosome 11 of a cDNA encoding a human opioid-binding cell adhesion molecule (OBCAM). Gene (1995) 0.92
Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells. Mol Pharmacol (1992) 0.90
Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum. J Pharmacol Exp Ther (1982) 0.89
Pregnancy augments nitric oxide-dependent dilator response to acetylcholine in the human uterine artery. Hum Reprod (1998) 0.89
Dynorphin: a possible modulatory peptide on morphine or beta-endorphin analgesia in mouse. Eur J Pharmacol (1981) 0.88
Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow. Eur J Pharmacol (1991) 0.88
Peptide inhibitor of morphine- and beta-endorphin-induced analgesia. Proc Natl Acad Sci U S A (1980) 0.86
Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice. Eur J Pharmacol (1992) 0.86
Dynorphin A modulates acute and chronic opioid effects. J Pharmacol Exp Ther (1995) 0.86
Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia. J Pharmacol Exp Ther (1981) 0.85
Enzymatic synthesis of D-alanyl-D-alanine. Control of D-alanine:D-alanine ligase (ADP). Biochemistry (1969) 0.85
Control of cation movements in liver mitochondria by a cytoplasmic factor. Biochem Biophys Res Commun (1971) 0.85
Identification of endogenous opioid receptor components in rat brain using a monoclonal antibody. Mol Pharmacol (1988) 0.84
Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration. Eur J Pharmacol (1988) 0.84
Dynorphin(1-13) improves survival in cats with focal cerebral ischaemia. Nature (1985) 0.83
beta-Endorphin: formation of alpha-helix in lipid solutions. Proc Natl Acad Sci U S A (1979) 0.83
[Des-Tyr1]dynorphin A-(2-17) has naloxone-insensitive antinociceptive effect in the writhing assay. J Pharmacol Exp Ther (1995) 0.83
Lipid requirement for mu opioid receptor binding. J Neurochem (1987) 0.83
Regulation by lysine of production of threonine-sensitive aspartokinase. Biochem Biophys Res Commun (1966) 0.83
Opioid-induced inhibition of voltage-gated calcium channels parallels expression of omega-conotoxin-sensitive channel subtype during differentiation of NG108-15 cells. Brain Res (1993) 0.83
Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice. J Pharmacol Exp Ther (1993) 0.83
Dynorphin-(1-13): effects in nontolerant and morphine-dependent rhesus monkeys. Eur J Pharmacol (1982) 0.82
Effects of high intravenous doses of dynorphin A(1-13) on tail flick latency and central nervous system histology in rats. Pharmacol Biochem Behav (1995) 0.82
[3H]morphine binding is enhanced by IL-1-stimulated thymocyte proliferation. FEBS Lett (1991) 0.81
Adaptation to ethanol-induced fluidization of brain lipid bilayers; cross-tolerance and reversibility. Mol Pharmacol (1980) 0.81
The downregulation of Bcl-2 expression is necessary for theophylline-induced apoptosis of eosinophil. Cell Immunol (2000) 0.80
Modification of opioid agonist binding by pertussis toxin. Brain Res (1987) 0.80
Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates. J Pharmacol Exp Ther (1986) 0.80
A monoclonal antibody that inhibits opioid binding to rat brain membranes. Biochem Biophys Res Commun (1988) 0.79
Functional opiate receptor in mouse vas deferens: evidence for a complex interaction. J Pharmacol Exp Ther (1983) 0.79
Treatment of stroke with opiate antagonists--effects of exogenous antagonists and dynorphin 1-13. Neuropeptides (1985) 0.79
Mouse brain DNA-dependent RNA polymerases after chronic morphine treatment. J Neurochem (1980) 0.79
Genetic mapping of opioid binding protein gene(s) to mouse chromosome 9. Mamm Genome (1993) 0.78
Effect of chronic morphine treatment on brain chromatin template activities in mice. Biochem Pharmacol (1975) 0.78
Specific reduction of delta-opioid receptor binding in transfected NG108-15 cells. J Biol Chem (1992) 0.78
Phosphorylation and methylation of chromatin proteins from mouse brain nuclei. J Neurochem (1977) 0.78
Interaction of dynorphin with neurotensin on the guinea pig ileum myenteric plexus. Life Sci (1983) 0.78
[3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type. J Pharmacol Exp Ther (1984) 0.78
Opioid-binding cell adhesion molecule (OBCAM)-related clones from a rat brain cDNA library. Gene (1992) 0.78
Regulation of mitochondrial metabolism by specific cellular substances. II. The nature of stimulation of mitochondrial glutamate metabolism by a cytoplasmic component. Biochemistry (1969) 0.78
Endogenous opioid peptides: comparative evaluation of their receptor affinities in the mouse brain. Life Sci (1983) 0.78
Mu type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to G-protein-mediated inhibition of adenylyl cyclase. FEBS Lett (1989) 0.78
Different molecular weight forms of opioid receptors revealed by polyclonal antibodies. Biochem Biophys Res Commun (1988) 0.78
Characterization of [3H]morphine binding to interleukin-1-activated thymocytes. J Pharmacol Exp Ther (1992) 0.78
Dynorphin blocks opioid inhibition of macrophage-colony stimulating factor-induced proliferation of bone marrow cells. Eur J Pharmacol (1991) 0.77
Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus. J Pharmacol Exp Ther (1984) 0.77
Mu-opioid receptor is associated with phosphatase activity. Biochem Biophys Res Commun (1986) 0.77
A study of lysyl-ribonucleic acid synthetase in relation to substrate conformation. Arch Biochem Biophys (1967) 0.77
Effect of dynorphin-(1-13) and related peptides on respiratory rate and morphine-induced respiratory rate depression. Eur J Pharmacol (1983) 0.77
Mu-type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to guanine nucleotide binding proteins. Brain Res (1989) 0.77
Characterization of beta-125I-endorphin cross-linked proteins in NG108-15 cell membranes. A 25-kilodalton protein with properties of delta-opioid-binding site. J Biol Chem (1992) 0.76
Activation of K-opiate sites by dynorphin in the myenteric plexus. Adv Biochem Psychopharmacol (1982) 0.76
Transfection of NG108-15 cells with antisense opioid-binding cell adhesion molecule cDNA alters opioid receptor-G-protein interaction. J Biol Chem (1993) 0.76
Dynorphin1-13: interaction with other opiate ligand bindings in vitro. Brain Res (1984) 0.76
Mathematical modeling of opiate binding to mouse brain membrane. Bull Math Biol (1985) 0.76
DynorphinA-(2-17) restores spinal/supraspinal morphine synergy in morphine-tolerant mice. J Pharmacol Exp Ther (1997) 0.76
Dynorphin effects on plasma concentrations of anterior pituitary hormones in the nonhuman primate. J Pharmacol Exp Ther (1986) 0.76
Non-opioid dynorphin binding site on secretory vesicles of a pituitary-derived cell line. Brain Res (1998) 0.76
A case of laboratory-acquired murine typhus. Korean J Intern Med (1990) 0.75
Dynorphin(1-13), a long-lasting inhibitor of opiate receptor binding in vitro. Life Sci (1983) 0.75
Dynorphin B-29: chemical synthesis and pharmacological properties in opioid systems in vitro. Neuropeptides (1984) 0.75
Regulation of an opioid-binding protein in NG108-15 cells parallels regulation of delta-opioid receptors. Proc Natl Acad Sci U S A (1992) 0.75
Morphine effects of RNA synthesis in purified oligodendroglial nuclei. Proc West Pharmacol Soc (1976) 0.75
Smoking in restaurants. Med J Aust (1998) 0.75
Effect of opiates on macromolecule biosynthesis. Adv Biochem Psychopharmacol (1979) 0.75
Different modes of opiate interaction in rat vas deferens. Life Sci (1983) 0.75
Dynorphin inhibition of opiate binding: specificity and reversibility in vitro. Proc West Pharmacol Soc (1983) 0.75
Conformation of beta-endorphin analogues in cerebroside sulfate solution. Mol Pharmacol (1981) 0.75
The effect of ethanol tolerance on cholesterol organization and Na+-K+-ATPase activity in rat brain membrane fractions. Proc West Pharmacol Soc (1981) 0.75
Morphine and beta-endorphin on RNA synthesis. Adv Biochem Psychopharmacol (1978) 0.75
In vivo incorporation of a cholesterol-like fluorescent probe into rat brain membranes. J Pharmacol Methods (1983) 0.75
Apparent protein kinase activity in oligodendroglial chromatin after chronic morphine treatment. Biochem Pharmacol (1976) 0.75
Beta-Endorphin receptor and its possible relationship to other opioid receptors. Adv Biochem Psychopharmacol (1982) 0.75
A study of deoxyribonucleic acid binding of narcotic analgesics. Biochem Pharmacol (1975) 0.75
Opioid peptides derived from pre-proenkephalin B sequence: biological evaluation in guinea pig ileum and mouse vas deferens. Proc West Pharmacol Soc (1983) 0.75
Circular dichroic study of beta-endorphin conformation induced by membrane acidic lipids. Adv Biochem Psychopharmacol (1980) 0.75
Dynorphin-(1-13): the effect of in vivo treatment on opiate bindings in vitro. Eur J Pharmacol (1983) 0.75
The dependence of oxidative phosphorylation and ATP-ase of liver mitochondria on bound Mg2+. Biochem Biophys Res Commun (1970) 0.75
Interaction of a cytoplasmic factor with electron and ion transfer coupled functions of mitochondria. Biochem Biophys Res Commun (1970) 0.75
Effect of acute and chronic ethanol treatment on rat brain phospholipid turnover. Biochem Pharmacol (1980) 0.75
Alterations of macromolecule biosynthesis after chronic administration of opiates and ethanol. Adv Exp Med Biol (1977) 0.75
Adaptation of brain lipid bilayers to ethanol-induced fluidization. Species and strain generality. Biochem Pharmacol (1980) 0.75
Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens. J Pharmacol Exp Ther (1982) 0.75
Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy. Eur J Pharmacol (1981) 0.75
Adaptation to ethanol-induced fluidization of brain lipid bilayers. Drug Alcohol Depend (1980) 0.75
Partial purification of nuclear protein kinase from small dense nuclei of mouse brain and the effect of chronic morphine treatment. J Neurochem (1980) 0.75
Partial purification of DNA-dependent RNA polymerases from small dense nuclei of mouse brain. Biochem Pharmacol (1978) 0.75
Characterization of microbial communities in exhaust air treatment systems of large-scale pig housing facilities. Water Sci Technol (2010) 0.75
Malate dehydrogenase of ox kidney. Comparison of the reactivity of sulfhydryl groups and their relationship to activities of the mitochondrial and cytoplasmic enzymes. Eur J Biochem (1970) 0.75
Is dynorphin a k ligand? Proc West Pharmacol Soc (1983) 0.75
Differential modification of opiate receptor activity by arylsulfatase treatment. Biochem Pharmacol (1983) 0.75
Decreased dihydromorphine and D-ALA2-D-LEU5-enkephalin binding in vitro after dynorphin pretreatment in mice in vivo. Life Sci (1983) 0.75
Possible nuclear protein kinase regulation of homologous ribonucleic acid polymerases from small dense nuclei of mouse brain during morphine tolerance-dependence. Involvement of cyclic 3',5'-adenosine monophosphate. Biochem Pharmacol (1981) 0.75